Providence Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Providence Capital Advisors's LLY Position: Q2 2026 in Review
Providence Capital Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 602 shares worth $722K. The position accounts for 0.11% of the portfolio, ranked #103.
Providence Capital Advisors first reported a position in LLY in Q1 2022 and has held it in 16 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Providence Capital Advisors held 602 shares of Eli Lilly worth $722K as of Q2 2026.
- Providence Capital Advisors left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 0.11% of Providence Capital Advisors's portfolio in Q2 2026, its #103 holding.
- Providence Capital Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 16 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.